Abstract
Recognition of cutaneous side effects of bleomycin, a commonly used chemotherapeutic agent, is important to avoid unnecessary discontinuation of therapy. Here, we present the case of a 15-year-old boy who was undergoing treatment with standard BEP (bleomycin, etoposide, and cisplatin) regime, presented with flagellate hyperpigmented lesions in the back, arm, and thighs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
